Shock: all 921 studies

Page 9 of 10. Open to participants first (171), then studies with results posted, then the rest; newest registration first within each.

• Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)CompletedNCT01668329
• The Metabolomics of Anaphylaxis to ImmunotherapyWithdrawnNCT01666288
• Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency SurgeryTerminatedNCT01653977Not applicable
• Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO PilotCompletedNCT01648036Phase 2
• Danish Cardiogenic Shock TrialCompletedNCT01633502Not applicable
• Central Venous Pressure Change With Volume Challenge in Patients With Hemodynamic InstabilityCompletedNCT01630577Phase 3
• Effects of Sedatives on Sublingual Microcirculation of Patients With Septic ShockCompletedNCT01618396Not applicable
• Red Blood Cell Transfusion Improves Perfusion Parameters in Septic Shock Patients With HypoperfusionCompletedNCT01611753Not applicable
• Endotoxin in Gram-negative Septic ShockStatus unknownNCT01602354
• Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock PatientsWithdrawnNCT01601938Phase 2
• Mitochondrial Function of Immune Cells in SepsisCompletedNCT01600989
• Echocardiographic Prediction of Fluid Responsiveness After a Mini-fluid Challenge in Non-ventilated Patients With ShockCompletedNCT01590511
• Early Detection of Neonatal ShockTerminatedNCT01550198
• Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress SyndromeCompletedNCT01526382Phase 1/2
• Procalcitonin Monitoring Sepsis StudyCompletedNCT01523717
• Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac SurgeryStatus unknownNCT01505231Phase 3
• Discontinuation Order of Vasopressors in Septic ShockTerminatedNCT01493102Not applicable
• Transfusion-requirements in Septic Shock TrialCompletedNCT01485315Phase 3
• The Cooling And Surviving Septic Shock Study (CASS)TerminatedNCT01455116Phase 2/3
• ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic ShockCompletedNCT01448109Phase 4
• Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic ShockCompletedNCT01433276Phase 3
• Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) ShocksStatus unknownNCT01430806Not applicable
• Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.CompletedNCT01411670Phase 2
• Effect of Monitoring of Pulse Index Continuous Cardiac Output (PiCCO) on Shock Patients in Intensive Care UnitStatus unknownNCT01397188Not applicable
• CardShock Study and RegistryCompletedNCT01374867
• Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic ShockCompletedNCT01367743Phase 4
• Clonal Mast Cell Disorders in Exercise-Induced AnaphylaxisStatus unknownNCT01326741
• The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock PatientsCompletedNCT01319630
• GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic ShockTerminatedNCT01315496Phase 3
• Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic ShockCompletedNCT01310790Phase 4
• Comparison of a Tissue Perfusion Guided Hemodynamic Protocol With a Standard Hemodynamic Protocol in Septic Shock PatientsTerminatedNCT01296789Not applicable
• Goal-directed Resuscitative Interventions During Pediatric Inter-facility Transport (The GRIPIT Trial)TerminatedNCT01293500Not applicable
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)CompletedNCT01284452Not applicable
• Effects of Dobutamine on Microcirculation, Regional and Peripheral Perfusion in Septic Shock PatientsCompletedNCT01271153Not applicable
• Thermodilution - Controlled Management of Volume Therapy in Septic ShockCompletedNCT01263977Not applicable
• Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock PatientsCompletedNCT01262196Phase 2
• Simultaneously Using Traditional Chinese Medicine (Si-Ni-Tang) to Treat Septic Shock PatientsTerminatedNCT01223430Phase 2
• Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic ShockCompletedNCT01222663Phase 3
• Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)Status unknownNCT01213914Not applicable
• Transpulmonary Thermodilution and Transesophageal Echocardiography in Early Septic ShockCompletedNCT01188993Phase 4
• Assessment of Transcutaneous Oxygen Tension/Oxygen Challenge Test in Intensive Care Unit (ICU) PatientsStatus unknownNCT01174966
• FLOTRAC/VIGILEO in Acute Circulatory FailureTerminatedNCT01090791
• The Effect of Erythropietin on Microcircualtory Alteration in Intensive Care Unit Patients With Severe SepsisTerminatedNCT01087450
• High Volume Veno-venous Hemofiltration Versus Standard Care for Post-cardiac Surgery ShockCompletedNCT01077349Not applicable
• Pilot Study of Bevacizumab (Avastin) in Patients With Septic ShockWithdrawnNCT01063010Not applicable
• Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic ControlCompletedNCT01013662Not applicable
• Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock PatientsCompletedNCT01004198Phase 2
• Terlipressin in Septic Shock: Effects on MicrocirculationCompletedNCT00995839Phase 2/3
• Phase I STEBVax in Healthy AdultsCompletedNCT00974935Phase 1
• Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)Status unknownNCT00966628Phase 3
• Scandinavian Starch for Severe Sepsis/Septic Shock TrialCompletedNCT00962156Phase 3
• Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer PatientsCompletedNCT00930085Not applicable
• Investigations of New Markers in Patients With ShockCompletedNCT00919685Not applicable
• Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue VirusCompletedNCT00919178Phase 1
• An Upgrading of the Resuscitative Patterns by Utilization of the Balanced Crystalloids and Synthetic Colloids and the Non-Invasive Hemodynamic Monitoring During Burn ShockStatus unknownNCT00914563Phase 2
• Posterior Tibial Artery Bypass for Iliofemoral Artery Injury Associated With Massive Blood Loss and ShockCompletedNCT00900848
• Norepinephrine as Early Vasopressor Therapy in Children Undergoing Mechanical VentilationStatus unknownNCT00894621Phase 4
• Brachial Artery Peak Velocity Variation to Predict Fluid ResponsivenessCompletedNCT00890071
• Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing AnaphylaxisCompletedNCT00868842
• Adrenal Insufficiency in Septic ShockTerminatedNCT00842933Phase 4
• Validity Study of a Nasal Valve ImplantStatus unknownNCT00837525Not applicable
• Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney InjuryStatus unknownNCT00837057Phase 4
• Avascular Necrosis (AVN) Long-Term Follow-upTerminatedNCT00833430
• Fluid Resuscitation in Early Septic ShockCompletedNCT00819416Phase 2
• Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic ShockTerminatedNCT00816790Phase 4
• Effects of Levosimendan on Microcirculation in Septic ShockCompletedNCT00800306Phase 2
• Terlipressin Administration in Septic Shock Refractory to CatecholaminesStatus unknownNCT00793559Phase 2
• Hemodynamic Efficiency of an Hemodialysis Treatment With High Permeability in Post-resuscitation ShockCompletedNCT00780299Phase 3
• Norepinephrine Weaning in Septic PatientsCompletedNCT00763906Phase 4
• Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention IndicationCompletedNCT00743522
• Surgical and Medical Emergencies on Board of European Aircraft CarriersCompletedNCT00713102
• Volume Replacement With Albumin in Severe SepsisCompletedNCT00707122Phase 3
• Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic ShockCompletedNCT00698048
• Tryptophan, Serotonin and Kynurenine in Septic ShockCompletedNCT00684736
• Phenylephrine in Septic ShockCompletedNCT00639015Phase 2
• Early Use of Polymyxin B Hemoperfusion in Abdominal SepsisCompletedNCT00629382Phase 4
• Terlipressin in Septic Shock in CirrhosisCompletedNCT00628160Phase 2/3
• Activated Protein C and Corticosteroids for Human Septic ShockCompletedNCT00625209Phase 3
• Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon CounterpulsationCompletedNCT00604331Phase 2
• Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockCompletedNCT00534287Phase 3
• External Cooling in Septic Shock PatientsCompletedNCT00527007Not applicable
• Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic ShockCompletedNCT00523198
• Intraaortic Balloon Pump in Cardiogenic Shock IICompletedNCT00491036Phase 4
• Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage: Zambia and ZimbabweCompletedNCT00488462Not applicable
• Continuous Infusion of Terlipressin in Septic ShockCompletedNCT00481572Phase 2
• Phenylephrine Versus Norepinephrine in Septic ShockCompletedNCT00481442Phase 2
• Aortic Balloon Counterpulastion in Myocardial Infarction Related ShockCompletedNCT00469248Not applicable
• A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma PatientsStatus unknownNCT00459160Not applicable
• Effects of Alkaline Phosphatase on Renal Function in Septic PatientsCompletedNCT00457613Phase 2
• Simvastatin in Patients With Septic ShockStatus unknownNCT00450840Phase 4
• Use of ECMO in Acute MIStatus unknownNCT00425685
• Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic ShockCompletedNCT00420030Phase 4
• Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)CompletedNCT00417378Phase 4
• Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation MonitoringCompletedNCT00407823Not applicable
• Skeletal Muscle Oxygenation in Critically IllStatus unknownNCT00384644
• Vasopressin in Traumatic Hemorrhagic Shock StudyCompletedNCT00379522Phase 2/3
• Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic ShockStatus unknownNCT00378586
• Protocol-driven Hemodynamic Support for Patients With Septic ShockStatus unknownNCT00335907Not applicable
• COMPACT - COMbining Plasma-filtration and Adsorption Clinical TrialTerminatedNCT00332371Not applicable
• Early Albumin Resuscitation During Septic ShockCompletedNCT00327704Phase 4

← Shock overview